PRESS RELEASE
Yuki Kinoshita Joins Pittsburgh-Based Contract Research Organization, Clinical Research Strategies, LLC as Clinical Research Associate
Pittsburgh, PA – March 19, 2024. Clinical Research Strategies, LLC (“CRS”), a Pittsburgh-area-based, US-owned and operated contract research organization (CRO) and executive management consultancy for the life sciences industry is pleased to announce the addition of Yuki Kinoshita, Clinical Research Associate (CRA), to the firm. Ms. Kinoshita earned a bachelor’s degree in public health with a clinical trials research concentration, magna cum laude, from Kent State University in May 2020, with membership in the Alpha Lambda Delta Collegiate Honor Society. She also received the University Award, President’s Scholarship, and Trustee Scholarship.
Photo by Jen Worley
Prior to joining CRS, Ms. Kinoshita worked for ALung Technologies and LivaLova, Inc. in clinical operations positions where she gained experience working on trial master files (TMFs), literature reviews, and clinical evaluation reports (CERs) for medical devices. She is dedicated to contributing to the CRS team and growing her skills in clinical research. In her spare time, Yuki enjoys pilates, hiking, and meditation.
“Ms. Kinoshita is a great addition to our clinical operations team and management consulting practice,” says Alethea Wieland, CRS President and Founder. CEO, David Link, MBA adds, “We are excited for Yuki to join us with a strong medical device background which will serve our key clients in their early journeys through regulatory authority discussions and substantiation of clinical performance.”
About Clinical Research Strategies, LLC:
CRS is a specialty CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up, mid-sized, and large life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.
Indications represented are precision medicine, immuno-oncology, central nervous system, infectious diseases, respiratory diseases, orthopedics, de novo devices, digital health and mobile apps, reproductive health, regenerative medicine, cardiology, major depressive disorder, opioid-sparing pain, cannabis, radiology, and critical care. CRS is a qualified service provider for federal grants.
CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, vaccine status, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.
# # #
Media Contact:
Ron MacDonald
Step2 Branding and Design
ronmac@step2branding.com
+1 724.814.4067
Alethea Wieland, President and Founder
Clinical Research Strategies, LLC
alethea@clinicalresearchstrategies.com
+1 724.272.1245